morocco
News items related to: Morocco
-
Activists File Patent Opposition to Challenge COVID-19 Drug Monopoly on Baricitinib
Activists from Morocco, Thailand, and Vietnam have filed patent oppositions to challenge drug manufacturers Incyte and Eli Lilly over the...
-
MMA and ITPC’s 3rd POA: building capacity to challenge low quality patents
The Academies aim to provide practical training and capacity building for civil society groups and activists in challenging pharmaceutical patents...
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
This week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
-
Moroccan civil society calls for compulsory licence on Gilead’s possible COVID-19 drug
On 12 May 2020, Gilead Sciences announced voluntary licenses to five generic manufacturers in India and Pakistan allowing them to...
-
Postponed: Global Summit on Intellectual Property and Access to Medicines
The 2020 summit will now take place at a later date, at a time when we are assured that international...
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
-
Activists ask pharma corporations: “Is the Middle East and North Africa a priority?”
A CAB meeting was held in Morocco, providing an opportunity to discuss access to treatment in a region facing an...
-
ICASA 2019: “Civil society will not leave the MENA region behind”
At the 20th International Conference on AIDS and STIs in Africa (ICASA 2019), treatment advocates drew attention to the factors...
-
Fixing the broken patent system: From Marrakech and back again
Marrakech was home to the signing of the TRIPS Agreement in 1995, an agreement that has been exploited by pharmaceutical...
-
GSIPA2M: The Summit Highlights
Catch up on the activity from our inaugural Global Summit on Intellectual Property and Access to Medicines (15-17 January 2018)....
-
GSIPA2M: Malaysia Ministry of Health 2018 winner of the Leadership Award on Intellectual Property and Access to Medicines
Malaysia’s “historic decision” to issue a compulsory license on Hep C medicine, sofosbuvir, stands up to Big Pharma, and will mean...
